Royal Netherlands Academy of Arts and Sciences

Nobel Laureate Hartmut Michel Joins Verseon's Scientific Advisory Board

Retrieved on: 
Wednesday, November 8, 2023
Royal Society, University of Frankfurt Institute for Social Research, Nobel Prize in Chemistry, Royal Netherlands Academy of Arts and Sciences, Foreign, Verseon, Research, German Academy of Sciences at Berlin, German National Academy of Sciences Leopoldina, American Physical Society, Biophysics, Science, University, Nobel Prize, Leibniz Prize, Cancer, Tuberculosis, Vaccine, Chemistry

FREMONT, Calif., Nov. 8, 2023 /PRNewswire/ -- Verseon is pleased to announce that Dr. Hartmut Michel, winner of the 1988 Nobel Prize in Chemistry, has joined the company's scientific advisory board. Dr. Michel's work in X-ray crystallography established improved methodologies for crystallizing cellular membrane proteins and elucidating their structures.

Key Points: 
  • FREMONT, Calif., Nov. 8, 2023 /PRNewswire/ -- Verseon is pleased to announce that Dr. Hartmut Michel, winner of the 1988 Nobel Prize in Chemistry, has joined the company's scientific advisory board.
  • Among the many awards and prizes Dr. Michel has received are the Biophysics Prize of the American Physical Society and the Gottfried Wilhelm Leibniz Prize , the highest honor awarded in German scientific research.
  • Verseon's team is excited to have Dr. Michel join the company's scientific advisory board.
  • We are honored to have him on our advisory board."

2023 RSC Award Winners

Retrieved on: 
Tuesday, September 12, 2023
Royal, Social, College, Royal Netherlands Academy of Arts and Sciences, Culture, Awards ceremony, Social science, RSC, Government, Social justice, Royal Society of Canada, Scientist, Knowledge, Science, Engagement, Royal Society, Civil engineering, Auction, Humanities

OTTAWA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The RSC announces 39 Award Winners for 2023.

Key Points: 
  • OTTAWA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The RSC announces 39 Award Winners for 2023.
  • What laureates bring to the advancement of knowledge is simply outstanding and will resonate both here and internationally,” said Alain-G. Gagnon, president of the RSC.
  • To learn more about the 2023 Award Winners, click here .
  • This year's award winners will be honored during the Awards Ceremony on Friday, November 17, 2023, as part of the 2023 RSC Celebration of Excellence and Engagement.

New RSC Fellows and College members 2023 Press Release

Retrieved on: 
Tuesday, September 5, 2023
Royal, College, Royal Netherlands Academy of Arts and Sciences, Culture, Social science, Research, RSC, Government, Science, Royal Society of Canada, Scientist, Fellows, Knowledge, Imagination, Royal Society, Management, Civil engineering, Humanities

OTTAWA, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The Royal Society of Canada (RSC) and its members have elected this year’s new Fellows and named the incoming class of the RSC College.

Key Points: 
  • OTTAWA, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The Royal Society of Canada (RSC) and its members have elected this year’s new Fellows and named the incoming class of the RSC College.
  • One hundred and one new Fellows have been elected by their peers for their outstanding scholarly, scientific and artistic achievement.
  • The RSC is also welcoming 58 new Members of the RSC College.
  • On Thursday, November 16, 2023, the RSC will welcome the 2023 new Members of the RSC College and on Friday, November 17, the Class of 2023 new RSC Fellows will be inducted for outstanding research and scholarly achievement.

City of Hope appoints Marcel van den Brink, M.D., Ph.D., as president of City of Hope Los Angeles and National Medical Center, and chief physician executive

Retrieved on: 
Tuesday, August 29, 2023
Immune reconstitution inflammatory syndrome, Royal Netherlands Academy of Arts and Sciences, City of Hope National Medical Center, City of Hope, Diabetes, Education, National Academy of Medicine, Duarte, Bone marrow, Cancer, American Association for Cancer Research, Research, BMT, City, National academy, Patient, Memorial Sloan Kettering Cancer Center, Science, Caligiuri, Haematopoietic system, Health, Transplant, DKMS, Pharmaceutical industry, Vaccine, Hope, Greater Los Angeles

He will also be responsible for ensuring that the most leading-edge patient care is available across the City of Hope system.

Key Points: 
  • He will also be responsible for ensuring that the most leading-edge patient care is available across the City of Hope system.
  • Van den Brink joins City of Hope after serving 24 years at Memorial Sloan Kettering Cancer Center, most recently as the head of its Division of Hematologic Malignancies.
  • Dr. van den Brink has had many other leadership roles, including vice-chairman of the board of the Deutsche Knochenmark Stiftung (DKMS).
  • Current City of Hope National Medical Center President Michael Caligiuri, M.D., will remain at City of Hope and transition to focus full time on his laboratory research.

PDD Holdings Announces Second Quarter 2023 Unaudited Financial Results

Retrieved on: 
Tuesday, August 29, 2023
Royal Netherlands Academy of Arts and Sciences, Advertising, Natural science, General counsel, IST, Engineering, Marketing, ADS, Food safety, PDD, Wageningen University & Research, KNAW, US, Investment, Toxicology, Webcast, Growth, Research, Annual report, Total, Video game, Management, Cryptocurrency, Bank

DUBLIN and SHANGHAI, Aug. 29, 2023 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the second quarter ended June 30, 2023.

Key Points: 
  • DUBLIN and SHANGHAI, Aug. 29, 2023 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the second quarter ended June 30, 2023.
  • Total revenues in the quarter were RMB52,280.7 million (US$17,209.8 million), an increase of 66% from RMB31,439.6 million in the same quarter of 2022.
  • Operating profit in the quarter was RMB12,718.8 million (US$1,754.0 million), an increase of 46% from RMB8,697.2 million in the same quarter of 2022.
  • Non-GAAP2 operating profit in the quarter was RMB14,609.4 million (US$2,014.7 million), an increase of 39% from RMB10,541.5 million in the same quarter of 2022.

Balancing environmental protection and economic growth

Retrieved on: 
Thursday, June 8, 2023
Royal Netherlands Academy of Arts and Sciences, Nature, Australian Academy of Science National Committees, Fertilizer, Farmer, Agriculture, Water quality, Survival, Florida Public Relations Association, STB, Chinese Academy of Agricultural Sciences, Nutrient, Hope, Head, China Agricultural University, Multimedia, Yunnan Provincial Museum, Chinese Academy of Engineering, Beijing Review, CAU, Harmony, National academy, Climate change, Soil, River, Yangxi, Water, Economic development, Science, Ecology, Nitrogen, Phosphorus, Dali Bai Autonomous Prefecture, Yunnan Agricultural University, Rare-earth element, Oil, Engineering

However, in the 1980s, the lake became so polluted that it emitted a putrid smell.

Key Points: 
  • However, in the 1980s, the lake became so polluted that it emitted a putrid smell.
  • The Yangxi, one of the 18 rivers that originate from Cangshan Mountain and empty into Erhai Lake, flows through the village.
  • Through their analysis of the water samples, the team found the farmland contributed 35 to 55 percent of the pollution.
  • Hans Lambers, a fellow with the Royal Netherlands Academy of Arts and Sciences and the Australian Academy of Science, told Beijing Review that short-term benefits are too often pursued despite greater long-term losses, when asked about the difficulties in balancing economic development and environmental protection.

LIXTE BIOTECHNOLOGY ANNOUNCES APPOINTMENT OF PROFESSOR RENÉ BERNARDS TO ITS BOARD OF DIRECTORS

Retrieved on: 
Wednesday, June 15, 2022
American Academy, Netherlands Cancer Institute, Association, Securities Exchange Act of 1934, American Association, Royal Netherlands Academy of Arts and Sciences, National academy, American Association for Cancer Research, Company, Drug combination, U.S. Securities and Exchange Commission, Biotechnology, Cancer, Research, PP2A, Securities Act of 1933, Marketing, Professor, Drug Quality and Security Act, CA, AACR, Bernards, Patient, Board of directors, Terminology, Board, Toxicity, Cell, International, GLOBE, Pharmaceutical industry, Director, Science

PASADENA, CA, June 15, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage pharmaceutical company focused on developing and commercializing cancer therapies, announced the appointment of Professor René Bernards to its Board of Directors. Professor Bernards will serve as an independent director.

Key Points: 
  • PASADENA, CA, June 15, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage pharmaceutical company focused on developing and commercializing cancer therapies, announced the appointment of Professor Ren Bernards to its Board of Directors.
  • Professor Bernards is a leader in the field of molecular carcinogenesis, working at the Netherlands Cancer Institute in Amsterdam.
  • He has also co-founded four biotechnology companies to bring his scientific discoveries to clinical oncology practice.
  • Dr. Kovach continued, Professor Bernards has received many awards recognizing his excellence in cancer research.

Crown Bioscience: First Clinical Candidate Developed Using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer

Retrieved on: 
Thursday, April 28, 2022
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Antibody, Drug discovery, Adult, Wellcome Sanger Institute, Metastasis, Organoid, Life, CEO, Immune-mediated inflammatory diseases, Catalan Institute of Nanotechnology, Royal Netherlands Academy of Arts and Sciences, Patient, Collection, Vall, Cancer, Technology, HUB, Growth, Crown Bioscience International, Achievement, Therapy, PDX, Senior, Multimedia, Wilms' tumor, Regenerative medicine, List of Nature Research journals, List of life sciences, Social, FP7, Colorectal cancer, EU, CRO, Meru Networks, Vaccine, Medical imaging, Pharmaceutical industry

Crown Bioscience and HUB led the design of the experiments which were executed using the high content screening platform from Crown Bioscience using HUB Organoids.

Key Points: 
  • Crown Bioscience and HUB led the design of the experiments which were executed using the high content screening platform from Crown Bioscience using HUB Organoids.
  • Follow up in vivo studies in matched patient-derived xenograft (PDX) models were also performed by Crown Bioscience.
  • This groundbreaking work demonstrates the power and potential of HUB Organoid Technology, commented Rob Vries PhD, CEO at HUB.
  • HUB Organoids (HUB) is the global leader in the field of adult stem cell-derived organoid.

DGAP-News: Anne Frank Fonds Basel protects copyrights to works by Anne Frank

Retrieved on: 
Tuesday, February 1, 2022
Anne Frank, KNAW, AFF, Racism, Royal Netherlands Academy of Arts and Sciences, VPN, AFS, Huygens Institute for the History of the Netherlands, Education, Geo-blocking, Diary, Online gambling

Works by Anne Frank have been uploaded onto a Belgian website, which is run by a letterbox company and uses geo-blocking.

Key Points: 
  • Works by Anne Frank have been uploaded onto a Belgian website, which is run by a letterbox company and uses geo-blocking.
  • The Anne Frank Fonds Basel (AFF) instigated a lawsuit against the letterbox company and against the Anne Frank Stichting and KNAW, as this covert bypassing of the protected copyright meant that the works of Anne Frank were also easily accessible in the Netherlands.
  • We will defend copyrights and take the appropriate measures in order to create legal certainty for the Anne Frank Fonds Basel, the publishing houses and its readers."
  • As the only organisation established by Otto Frank, the Anne Frank Fonds (AFF) was founded in 1963 and represents the Frank family.

Pittcon Announces Keynote Lecture

Retrieved on: 
Tuesday, September 21, 2021
Science, FEBS, ACS, IMSF, EMBO, Wallace H. Coulter, NWO, Mass spectrometry, Congress Center, Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, The arts, Mass, Thomson Medal, Georgia World Congress Center, Sir Hans Krebs Medal, Utrecht University, Wallace, Field, Proteomics, European Union, Faculty, Royal Netherlands Academy of Arts and Sciences, Research, Lecture, University of Georgia (Tbilisi), Education, GLOBE, Pharmaceutical industry

Pittsburgh, Pennsylvania, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Pittcon is honored to announce Professor Albert J. R. Heck as the 2022 Wallace H. Coulter Lecturer.

Key Points: 
  • Pittsburgh, Pennsylvania, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Pittcon is honored to announce Professor Albert J. R. Heck as the 2022 Wallace H. Coulter Lecturer.
  • The 2022 Coulter Lecture is entitled New Horizons in Mass Spectrometry: Sizing and Counting Particles by Native Mass Spectrometry.
  • Albert J. R. Heck is Distinguished Faculty Professor at the Science Faculty of Utrecht University (the Netherlands).
  • Pittcon is a catalyst for the exchange of information, a showcase of the latest advances in laboratory science, and a venue for international connectivity.